A Randomized Feasibility Study of Letrozole in Postmenopausal Women at Increased Risk for Development of Breast Cancer as Evidenced by High Breast Density.
Phase of Trial: Phase II
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 01 Apr 2010 Results have been published in Breast Cancer Research and Treatment.
- 16 Jan 2010 Planned end date (9 Jun 2006) added from National Cancer Institute of Canada record.